Skip to Main Content

Author Details

Salvatore Piscuoglio
University of Basel
2008
150
43
PMIDPaper TitleJournal TitlePublished Year
36796655PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data.Genomics2023
37626656Colitis Is Associated with Loss of the Histidine Phosphatase LHPP and Upregulation of Histidine Phosphorylation in Intestinal Epithelial Cells.Biomedicines2023
37509411Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients.Cancers (Basel)2023
37389703Cylindroma of the breast with CYLD gene mutation: a case report and review of the literature.Mol Biol Rep2023
37295433Minor intron splicing is critical for survival of lethal prostate cancer.Mol Cell2023
37294349PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer.J Mammary Gland Biol Neoplasia2023
36724278PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition.Sci Adv2023
36749655DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations.Cancer Res2023
34863035Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma.Mol Oncol2022
35804847The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples.Cancers (Basel)2022
35508466Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages.Nat Commun2022
35504881Alterations in homologous recombination repair genes in prostate cancer brain metastases.Nat Commun2022
35603298Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report.Commun Med (Lond)2022
35789568Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report.Commun Med (Lond)2022
35787660Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.Commun Biol2022
35389756Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T.Circulation2022
35814741The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective.Front Med (Lausanne)2022
36517508Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.Nat Commun2022
36419107The prognostic significance of CXCR4 and SDF-1 in differentiated thyroid cancer depends on CD8+ density.BMC Endocr Disord2022
36214135Response by du Fay de Lavallaz et al to Letter Regarding Article, "Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T".Circulation2022
36307545Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq.Commun Biol2022
35987910Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis.Nat Commun2022
36165931PD-L1 Expression in Triple-negative Breast Cancer-a Comparative Study of 3 Different Antibodies.Appl Immunohistochem Mol Morphol2022
33830625Genomic characterization of small cell carcinomas of the uterine cervix.Mol Oncol2022
35132819miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed Liver.Hepatol Commun2022
35083141Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues.Front Oncol2022
35263170Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.JCO Precis Oncol2022
33021035The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.Mol Oncol2021
33602919Patient-derived xenografts and organoids model therapy response in prostate cancer.Nat Commun2021
33734917Nestin and CD34 expression in colorectal cancer predicts improved overall survival.Acta Oncol2021
33894304Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma.J Control Release2021
33754045Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis.Theranostics2021
33860124Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members.Hepatol Commun2021
34664408YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis.EMBO Mol Med2021
34712603The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas.Front Oncol2021
34830938High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival.Cancers (Basel)2021
34250397Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study.JCO Precis Oncol2021
34129813ZNRF3 and RNF43 cooperate to safeguard metabolic liver zonation and hepatocyte proliferation.Cell Stem Cell2021
34272356USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis.Oncogenesis2021
34348664Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma.BMC Genomics2021
34012793Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung.Transl Lung Cancer Res2021
33934365Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens.J Pathol2021
34341503mTOR signaling mediates ILC3-driven immunopathology.Mucosal Immunol2021
34313788Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens.Nucleic Acids Res2021
34088870Mapping of m<sup>6</sup>A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistance.Mol Cancer Res2021
33436863Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.Sci Rep2021
32407542Discovery of heterozygous KRT10 alterations in MAUIE cases underlines the importance of regular skin cancer screening in ichthyosis with confetti.Br J Dermatol2020
31883437Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies.Cancer Cytopathol2020
33144576Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.Nat Commun2020
33137577Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing.Lung Cancer2020
  • 1 - 50 of 150

Recommended Authors

Yari Ciani
University of Trento
Career Start Year 2012
Number of shared co-authors 5
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 8
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 2
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 21
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 4
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 9
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 13
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 5
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 4
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 36
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 5
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 2
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 27
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 14
Olaf Neumann
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2002
Number of shared co-authors 1
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 1
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 4
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 2
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 6
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 8
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 3
David G Huntsman
University of British Columbia
Career Start Year 1994
Number of shared co-authors 13
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 8
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 17
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 11

Collaborators

Charlotte K Y Ng
University of Bern
Co-authored papers 100
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 55
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 55
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 24
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 24
Luciano G Martelotto
Monash University
Co-authored papers 21
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Co-authored papers 20
Kathleen A Burke
Brown University
Co-authored papers 16
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers 14
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers 12
Nicola Fusco
IEO European Institute of Oncology IRCCS
Co-authored papers 10
Rita A Sakr
Universite Libre de Bruxelles
Co-authored papers 9
Mark A Rubin
University of Bern
Co-authored papers 9
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Robert A Soslow
Co-authored papers 8
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Melissa P Murray
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Tari A King
Co-authored papers 6
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 6
Michael F Berger
Co-authored papers 5
Niko Beerenwinkel
ETH Zurich
Co-authored papers 5
Huei-Chi Wen
Co-authored papers 4
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Co-authored papers 4
Agnes Viale
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Holger Moch
University Hospital Zurich
Co-authored papers 3
David N Brown
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Mihaela Zavolan
Co-authored papers 3
Nora Katabi
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 3
Ronglai Shen
Co-authored papers 3
Release 1.2